Shares of US clinical-stage biotech Allogene Therapeutics rocketed 41% to $1.99 on Friday, as it announced the publication of ...
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Caribou Biosciences, Inc. (NASDAQ: CRBU) between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback